Symbol="MNKD"
AssetType="Common Stock"
Name="MannKind Corp"
Description="MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutics for endocrine and orphan lung diseases in the United States. The company is headquartered in Westlake Village, California."
CIK="899460"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="30930 RUSSELL RANCH ROAD, SUITE 300, WESTLAKE VILLAGE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1033436000"
EBITDA="-44574000"
PERatio="None"
PEGRatio="-0.23"
BookValue="-0.966"
DividendPerShare="0"
DividendYield="0"
EPS="-0.28"
RevenuePerShareTTM="0.494"
ProfitMargin="-0.554"
OperatingMarginTTM="-0.395"
ReturnOnAssetsTTM="-0.105"
ReturnOnEquityTTM="0"
RevenueTTM="128404000"
GrossProfitTTM="42273000"
DilutedEPSTTM="-0.28"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.388"
AnalystTargetPrice="6.4"
TrailingPE="-"
ForwardPE="303.03"
PriceToSalesRatioTTM="16.5"
PriceToBookRatio="-"
EVToRevenue="18.71"
EVToEBITDA="-22.02"
Beta="1.523"
num_52WeekHigh="5.73"
num_52WeekLow="2.91"
num_50DayMovingAverage="4.182"
num_200DayMovingAverage="4.297"
SharesOutstanding="264306000"
DividendDate="2017-03-03"
ExDividendDate="None"
symbol="MNKD"
open="3.90"
high="4.07"
low="3.89"
price="3.91"
volume="1974269.00"
latest_trading_day="2023-07-07"
previous_close="3.92"
change="-0.01"
change_percent="-0.2551%"
aroon_positive_momentum_days="41"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="41"
Volume_recent_avg="3131991"
Change_recent_avg="-0.02"
Delta_recent_avg="0.19"
Variance_recent_avg="0.1"
Change_ratio_recent_avg="-0.39"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="41"
Aroon_momentum_negative="59"
image_negative_thumbnail_id_1="99"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0077.jpeg"
image_negative_thumbnail_id_2="492"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0113.jpeg"
image_neutral_thumbnail_id_1="552"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_neutral_thumbnail_id_2="540"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_positive_thumbnail_id_1="695"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0013.jpeg"
image_positive_thumbnail_id_2="1003"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0165.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
